Warning letter
Beaumont Products, Inc.: warning letter of Dec 11, 2002
FDA warning letter UCM145350 · Atlanta District Office
Key facts
| Reference number | UCM145350 |
|---|---|
| Company | Beaumont Products, Inc. |
| Subject | Unapproved New Drug/GMP for Finished Pharmaceuticals/Misbranded |
| Issue date | Dec 11, 2002 |
| Posted date | Dec 11, 2002 |
| Issuing office | Atlanta District Office |
| Product type | Drugs |
| CFR sections cited | 211.166(a), 211, 211.22, 211.84, 211.100, 211.188, 211.42(b), 211.67(a), 211.113(a), 211.67(c) |
| Country | 3 |
| Inspection city | Kennesaw |
| Inspection ZIP | 30144-7040 |
| Inspection start date | Jul 16, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: